ACS
Archford Capital Strategies Portfolio holdings
AUM
$782M
1-Year Return
16.93%
This Quarter Return
+7.77%
1 Year Return
+16.93%
3 Year Return
+57.74%
5 Year Return
+86.93%
10 Year Return
+191.61%
AUM
$435M
AUM Growth
+$47.5M
(+12%)
Cap. Flow
+$21.9M
Cap. Flow
% of AUM
5.04%
Top 10 Holdings %
Top 10 Hldgs %
25.97%
Holding
298
New
26
Increased
134
Reduced
94
Closed
26
Top Buys
| 1 |
Vanguard Total Bond Market
BND
|
$10.6M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$10.3M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$5.43M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
$4.31M |
| 5 |
Strategas Macro Thematic Opportunities ETF
SAMT
|
$3.31M |
Top Sells
Sector Composition
| 1 | Technology | 12.21% |
| 2 | Healthcare | 6.63% |
| 3 | Financials | 5.75% |
| 4 | Consumer Staples | 4.06% |
| 5 | Industrials | 3.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Teradyne
TER
$19B
| $704K | 0.16% |
8,056
-407
| -5% | -$35.6K |
|
152
Sanofi
SNY
$111B
| $698K | 0.16% |
14,403
+271
| +2% | +$13.1K |
|
153
AT&T
T
$212B
| $689K | 0.16% |
37,400
+11,320
| +43% | +$208K |
|
154
Gilead Sciences
GILD
$140B
| $688K | 0.16% |
8,017
+670
| +9% | +$57.5K |
|
155
3M
MMM
$82.8B
| $685K | 0.16% |
6,833
+727
| +12% | +$72.9K |
|
156
T Rowe Price
TROW
$24.5B
| $683K | 0.16% |
6,265
+2,125
| +51% | +$232K |
|
157
Merck
MRK
$210B
| $681K | 0.16% |
6,138
+159
| +3% | +$17.6K |
|
158
Constellation Brands
STZ
$25.7B
| $681K | 0.16% |
2,937
-148
| -5% | -$34.3K |
|
159
Uber
UBER
$192B
| $680K | 0.16% |
27,503
-4,639
| -14% | -$115K |
|
160
RTX Corp
RTX
$212B
| $679K | 0.16% |
6,726
-22
| -0.3% | -$2.22K |
|
161
Realty Income
O
$53.3B
| $674K | 0.15% |
10,620
-204
| -2% | -$12.9K |
|
162
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.26B
| $663K | 0.15% |
+27,410
| New | +$663K |
|
163
Sprout Social
SPT
$874M
| $658K | 0.15% |
11,650
-10,000
| -46% | -$565K |
|
164
Global Payments
GPN
$21.2B
| $653K | 0.15% |
+6,570
| New | +$653K |
|
|
ABB
165
DELISTED
ABB Ltd.
ABB
| $648K | 0.15% |
21,284
+6,590
| +45% | +$201K |
|
166
SS&C Technologies
SSNC
$21.7B
| $648K | 0.15% |
+12,441
| New | +$648K |
|
167
Zoetis
ZTS
$67.9B
| $638K | 0.15% |
4,356
-216
| -5% | -$31.7K |
|
168
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$3.45B
| $630K | 0.15% |
13,195
+4,273
| +48% | +$204K |
|
169
iShares ESG Aware MSCI USA ETF
ESGU
$14.3B
| $629K | 0.14% |
7,423
-46,278
| -86% | -$3.92M |
|
170
CVS Health
CVS
$93.5B
| $626K | 0.14% |
6,715
+75
| +1% | +$6.99K |
|
171
Pacific Biosciences
PACB
$372M
| $601K | 0.14% |
73,479
-9,183
| -11% | -$75.1K |
|
172
iShares Russell 1000 Value ETF
IWD
$63.7B
| $596K | 0.14% |
3,933
+646
| +20% | +$98K |
|
173
Salesforce
CRM
$233B
| $588K | 0.14% |
4,433
-303
| -6% | -$40.2K |
|
174
Workday
WDAY
$61.7B
| $582K | 0.13% |
3,477
-723
| -17% | -$121K |
|
175
Principal Financial Group
PFG
$18.1B
| $580K | 0.13% |
6,913
+672
| +11% | +$56.4K |
|